Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-steroidal anti-inflammatory medication in cataract surgery
2015-005313-79Phase 4Completed
- Sponsor
- Raimo Tuuminen
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in senile cataract (ARC), Irvine-Gass syndrome (IGS), posterior capsule opacification (PCO) and 1 more comparing Dicloabak with Nevanac (2 arms). Primary endpoints: Best corrected visual acuity, Intraocular pressure and 2 more. Started Nov 2016; status: completed.
02
Drugs
diclofenacnepafenac
03
Conditions
senile cataract (ARC)Irvine-Gass syndrome (IGS)posterior capsule opacification (PCO)Postoperative ocular inflammation
Beyond the preview
Go deeper on 2015-005313-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005313-79.